Abstract
The pharmaceutical industry is increasingly turning to Big Data analytics to accelerate drug discovery and development processes. By analyzing vast datasets from diverse sources such as clinical trials, genomics, and patient records, pharmaceutical companies can gain insights into drug efficacy, safety, and potential market success. This paper explores the applications of Big Data in drug development, highlighting how it is transforming the way drugs are identified, tested, and developed.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Dr. Oliver Thompson (Author)
Downloads
Download data is not yet available.